Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ibuprofen Lysine
2. 57469-76-8
3. Ibuprofen Dl-lysine
4. Ibuprofen D,l-lysinate
5. 079x7dl13m
6. (rs)-2-(4-(2-methylpropyl)phenyl)propanoic Acid D,l-lysine Salt
7. 2,6-diaminohexanoic Acid Compound With 2-(4-isobutylphenyl)propanoic Acid (1:1)
8. (rs)-2-[4-(2-methylpropyl)phenyl]propanoic Acid D,l-lysine Salt
9. (2s)-2,6-diaminohexanoic Acid;2-[4-(2-methylpropyl)phenyl]propanoic Acid
10. Neoprofen;ibuprofen-lys
11. Starbld0004237
12. Schembl44616
13. Unii-079x7dl13m
14. Dtxsid50432054
15. Bcp27681
16. Akos015963349
17. Ac-19865
18. Ac-32764
19. Ft-0670261
20. Ft-0670262
21. Lysine, Mono(alpha-methyl-4-(2-methylpropyl)benzeneacetate)
22. Dl-lysine, Mono(alpha-methyl-4-(2-methylpropyl)benzeneacetate)
23. Lysine, Alpha-methyl-4-(2-methylpropyl)benzeneacetate (1:1)
24. Dl-lysine, Mono(.alpha.-methyl-4-(2-methylpropyl)benzeneacetate)
25. Lysine, .alpha.-methyl-4-(2-methylpropyl)benzeneacetate (1:1)
26. Lysine, Mono(.alpha.-methyl-4-(2-methylpropyl)benzeneacetate)
27. Benzeneacetic Acid, .alpha.-methyl-4-(2-methylpropyl)-, Compd. With Lysine (1:1)
28. Benzeneacetic Acid, Alpha-methyl-4-(2-methylpropyl)-, Compd. With Lysine (1:1)
| Molecular Weight | 352.5 g/mol |
|---|---|
| Molecular Formula | C19H32N2O4 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | 352.23620751 g/mol |
| Monoisotopic Mass | 352.23620751 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 309 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ANALYTICAL
ABOUT THIS PAGE
39
PharmaCompass offers a list of Ibuprofen Lysinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ibuprofen Lysinate manufacturer or Ibuprofen Lysinate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibuprofen Lysinate manufacturer or Ibuprofen Lysinate supplier.
PharmaCompass also assists you with knowing the Ibuprofen Lysinate API Price utilized in the formulation of products. Ibuprofen Lysinate API Price is not always fixed or binding as the Ibuprofen Lysinate Price is obtained through a variety of data sources. The Ibuprofen Lysinate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 57469-76-8 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 57469-76-8, including repackagers and relabelers. The FDA regulates 57469-76-8 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 57469-76-8 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 57469-76-8 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 57469-76-8 supplier is an individual or a company that provides 57469-76-8 active pharmaceutical ingredient (API) or 57469-76-8 finished formulations upon request. The 57469-76-8 suppliers may include 57469-76-8 API manufacturers, exporters, distributors and traders.
click here to find a list of 57469-76-8 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 57469-76-8 DMF (Drug Master File) is a document detailing the whole manufacturing process of 57469-76-8 active pharmaceutical ingredient (API) in detail. Different forms of 57469-76-8 DMFs exist exist since differing nations have different regulations, such as 57469-76-8 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 57469-76-8 DMF submitted to regulatory agencies in the US is known as a USDMF. 57469-76-8 USDMF includes data on 57469-76-8's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 57469-76-8 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 57469-76-8 suppliers with USDMF on PharmaCompass.
A 57469-76-8 written confirmation (57469-76-8 WC) is an official document issued by a regulatory agency to a 57469-76-8 manufacturer, verifying that the manufacturing facility of a 57469-76-8 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 57469-76-8 APIs or 57469-76-8 finished pharmaceutical products to another nation, regulatory agencies frequently require a 57469-76-8 WC (written confirmation) as part of the regulatory process.
click here to find a list of 57469-76-8 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 57469-76-8 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 57469-76-8 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 57469-76-8 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 57469-76-8 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 57469-76-8 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 57469-76-8 suppliers with NDC on PharmaCompass.
57469-76-8 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 57469-76-8 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 57469-76-8 GMP manufacturer or 57469-76-8 GMP API supplier for your needs.
A 57469-76-8 CoA (Certificate of Analysis) is a formal document that attests to 57469-76-8's compliance with 57469-76-8 specifications and serves as a tool for batch-level quality control.
57469-76-8 CoA mostly includes findings from lab analyses of a specific batch. For each 57469-76-8 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
57469-76-8 may be tested according to a variety of international standards, such as European Pharmacopoeia (57469-76-8 EP), 57469-76-8 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (57469-76-8 USP).
